1. Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm. 2015; 2:e163.
Article
2. Amano H, Miyamoto N, Shimura H, Sato DK, Fujihara K, Ueno S, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. BMC Neurol. 2014; 14:224.
Article
3. Nakamura Y, Nakajima H, Tani H, Hosokawa T, Ishida S, Kimura F, et al. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC Neurol. 2017; 17:76.
Article
4. Waters P, Woodhall M, O'Connor KC, Reindl M, Lang B, Sato DK, et al. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. 2015; 2:e89.
Article
5. Lambert N, Strebel P, Orenstein W, Icenogle J, Poland GA. Rubella. Lancet. 2015; 385:2297–2307.
Article
6. Evans AS. Viral infections of humans: epidemiology and control. 2nd ed. New York: Springer;1984.
7. Cansu A, Ayşe S, Şengül Ö, Kivilcim G, Tuğba HL. Bilateral isolated acute optic neuritis in a child after acute rubella infection. Jpn J Ophthalmol. 2005; 49:431–433.
Article
8. Cong H, Jiang Y, Tien P. Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus. J Virol. 2011; 85:11038–11047.
Article
9. Besson Duvanel C, Honegger P, Matthieu JM. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures. J Neurosci Res. 2001; 65:446–454.
Article
10. Shinoda K, Asahara H, Uehara T, Miyoshi K, Suzuki SO, Iwaki T, et al. Multiphasic acute disseminated encephalomyelitis associated with atypical rubella virus infection. Mult Scler. 2015; 21:252–254.
Article
11. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017; 140:3128–3138.
Article
12. Peschl P, Bradl M, Höftberger R, Berger T, Reindl M. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases. Front Immunol. 2017; 8:529.
Article